Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4376618 | 1.00 | ACHE (0.93) | — | |
| Hydrochloric Acid SCHEMBL10938359 | 1.00 | ACHE (0.93) | — | |
| Hydrochloric Acid SCHEMBL31223994 | 0.97 | ACHE (0.87) | — | |
| SCHEMBL11887 | 0.96 | — | — | |
| SCHEMBL8469646 | 0.96 | ACHE (1.00) | — | |
| SCHEMBL6463424 | 0.93 | — | — | |
| Fluoride SCHEMBL7708424 | 0.93 | ACHE (0.93) | — | |
| SCHEMBL1439188 | 0.93 | — | — | |
| Ethane SCHEMBL7215590 | 0.93 | ACHE (0.93) | — | |
| Water SCHEMBL8599810 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118767993-A | Process for deactivation of olefin oligomerization catalysts | 沙特基础工业全球技术有限公司 | 2024-10-15 | — | — | CN | claimed |
| EP-3350143-B1 | PROCESS FOR DEACTIVATION OF AN OLEFIN OLIGOMERIZATION CATALYST | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2024-05-15 | — | — | EP | claimed |
| CN-115105448-B | Preparation method and application of skin care product raw materials for preventing radiation, promoting blood circulation, nourishing face and resisting aging | 秦皇岛普润高科技发展有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-116270345-A | Natural herbal cosmetic with effects of radiation protection, blood circulation activating, skin nourishing and anti-aging and application thereof | 广东瀚润生物科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-115819297-A | Preparation method of 2-nitro-4-methylsulfonylbenzoic acid | 南京先进生物材料与过程装备研究院有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-113773840-B | Etching solution and preparation method and application thereof | 晶瑞电子材料股份有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-110261194-B | Preparation method of drug detection equipment check product and drug detection equipment check product | 深圳砺剑防卫技术有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-113773840-A | Etching solution and preparation method and application thereof | 晶瑞电子材料股份有限公司 | 2021-12-10 | — | — | CN | claimed |
| CN-110981934-B | Synthetic method of argatroban hydrate | 鲁南制药集团股份有限公司 | 2021-05-25 | — | — | CN | claimed |
| US-20200131431-A1 | CHEMICAL ADDITIVES AND SURFACTANT COMBINATIONS FOR FAVORABLE WETTABILITY ALTERATION AND IMPROVED HYDROCARBON RECOVERY FACTORS | ALCHEMY SCIENCES INC (US) | 2020-04-30 | — | — | US | claimed |
| US-20100120721-A1 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | WOCKHARDT RESEARCH CENTRE (IN) | 2010-05-13 | — | — | US | claimed |
| EP-2069339-A2 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | Wockhardt Research Centre (IN) | 2009-06-17 | — | — | EP | claimed |
| WO-2008038092-A2 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | WOCKHARDT RESEARCH CENTRE (IN) | 2008-04-03 | — | — | WO | claimed |
| EP-1897881-A2 | Compounds useful for the treatment of obesity, type II diabetes and CNS disorders | Biovitrum AB (publ) (SE) | 2008-03-12 | — | — | EP | claimed |
| EP-1513828-A1 | NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS | Biovitrum AB (SE) | 2005-03-16 | — | — | EP | claimed |
| US-20040024210-A1 | New compounds | PROXIMAGEN NEUROSCIENCE PLC (GB) | 2004-02-05 | — | — | US | claimed |
| WO-2004000828-A1 | NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS | BIOVITRUM AB (SE) | 2003-12-31 | — | — | WO | claimed |
| EP-0096319-B1 | METHOD FOR PREVENTING SCALE DEPOSITION IN THE POLYMERIZATION OF ETHYLENICALLY UNSATURATED MONOMERS | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-03-26 | — | — | EP | claimed |
| EP-0096319-A1 | Method for preventing scale deposition in the polymerization of ethylenically unsaturated monomers | Shin-Etsu Chemical Co., Ltd. (JP) | 1983-12-21 | — | — | EP | claimed |
| US-4115436-A | REACTING AN ALKALI METAL P-STYRENESULFONATE WITH AN AMINE, THEN WITH AMMONIA | TOYO SODA MANUFACTURING CO., LTD. (JP) | 1978-09-19 | — | — | US | claimed |